Skip to main content

Table 2 Clinical characteristics of FMF patients with long-term remission

From: Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study

Variable

Remission group1

Control

P value

N = 33

N = 33

FMF attacks (%)

   

 Peritonitis

81.8

97.0

.052

 Arthritis

24.2

48.5

.036

 ELE

12.1

39.4

.011

 Pleuritis

21.2

51.5

.010

Non-attack manifestations (%)

   

 Exertional leg-pain

18.2

42.4

.030

 Splenomegaly

15.2

12.1

.500

 Anemia

3.0

18.2

.052

 Proteinuria or amyloidosis2

0

3.0

.500

 Renal failure

0

6.1

.246

 Dialysis

0

3.0

.500

Treatment (%)

   

 Good response to colchicine3

100.0

87.9

.057

 Colchicine dose ≥ 2 mg/day4

9.1

51.5

<.001

Severity score (%)

   

 Mild

69.7

33.3

.003

 Moderate or severe

30.3

66.7

 

Elevated APRs (%)

0

30

 
  1. ELE Erysipelas like erythema. APRs Acute phase reactants (ESR or CRP). 1Over the entire course of their disease. 2Biopsy proven.3Defined as less than one attack per month while on colchicine treatment.4Adjusted according to patient’s response.